Literature DB >> 3338378

Chronic and remitting painful diabetic polyneuropathy. Correlations with clinical features and subsequent changes in neurophysiology.

R J Young1, D J Ewing, B F Clarke.   

Abstract

Twenty-nine diabetic patients (19 men, 10 women) aged 19-71 yr with newly developed painful polyneuropathy were studied prospectively for 12-18 mo. Pain remitted completely in 16 patients within 12 mo, but continued in the other 13 patients. At presentation, no differences were found in the type or prevalence of symptoms or neurophysiological measurements (electrophysiology and cardiovascular autonomic function tests) between the patients whose pain remitted and those whose pain continued. Most electrophysiological measurements improved slightly in remitting patients but deteriorated slightly in those whose pain continued to reveal a significant difference (P less than .05) between the groups on final review. Similarly, abnormal autonomic nerve function improved slightly when pain remitted but worsened or persisted in patients whose pain continued, again revealing a significant difference between the groups (P less than .05) on final review. We also observed that pain remission usually occurred if the onset of symptoms shortly followed some sudden metabolic change (e.g., rapid improvement in glycemic control, ketoacidosis, anorexia nervosa) when the duration of diabetes was relatively short or when considerable weight loss preceded the onset of pain. We suggest that remitting and chronic painful diabetic polyneuropathy have distinctive clinical features at presentation and detectable neurophysiological differences during their symptomatic evolution.

Entities:  

Mesh:

Year:  1988        PMID: 3338378     DOI: 10.2337/diacare.11.1.34

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Brain       Date:  2014-11-11       Impact factor: 13.501

2.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

Review 3.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 4.  Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.

Authors:  Christopher H Gibbons; Ann Goebel-Fabbri
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

Review 5.  Clinical observations and experiments in diabetic neuropathy.

Authors:  P J Watkins
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

Review 6.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 7.  Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.

Authors:  J W Steele; D Faulds; K L Goa
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

Review 8.  Pathways in the diagnosis and management of diabetic polyneuropathy.

Authors:  Michelle Kaku; Aaron Vinik; David M Simpson
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

Review 9.  Painful diabetic neuropathy: advantage of novel drugs over old drugs?

Authors:  Dan Ziegler
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.

Authors:  Aaron I Vinik; Carolina M Casellini
Journal:  Diabetes Metab Syndr Obes       Date:  2013-02-22       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.